- Home
- INVE vs CLYM Comparison
INVE vs CLYM Comparison
Compare INVE & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- CLYM
- Stock Information
- Founded
- INVE 1990
- CLYM 2018
- Country
- INVE United States
- CLYM United States
- Employees
- INVE N/A
- CLYM N/A
- Industry
- INVE Computer peripheral equipment
- CLYM
- Sector
- INVE Technology
- CLYM
- Exchange
- INVE Nasdaq
- CLYM NYSE
- Market Cap
- INVE 82.7M
- CLYM 83.8M
- IPO Year
- INVE 1997
- CLYM 2021
- Fundamental
- Price
- INVE $3.45
- CLYM $1.51
- Analyst Decision
- INVE Strong Buy
- CLYM Buy
- Analyst Count
- INVE 3
- CLYM 1
- Target Price
- INVE $6.50
- CLYM $10.00
- AVG Volume (30 Days)
- INVE 112.4K
- CLYM 389.9K
- Earning Date
- INVE 08-07-2025
- CLYM 08-13-2025
- Dividend Yield
- INVE N/A
- CLYM N/A
- EPS Growth
- INVE N/A
- CLYM N/A
- EPS
- INVE 3.12
- CLYM N/A
- Revenue
- INVE $25,239,000.00
- CLYM N/A
- Revenue This Year
- INVE N/A
- CLYM N/A
- Revenue Next Year
- INVE $9.00
- CLYM N/A
- P/E Ratio
- INVE $1.12
- CLYM N/A
- Revenue Growth
- INVE N/A
- CLYM N/A
- 52 Week Low
- INVE $2.86
- CLYM $1.05
- 52 Week High
- INVE $4.29
- CLYM $9.21
- Technical
- Relative Strength Index (RSI)
- INVE 63.31
- CLYM N/A
- Support Level
- INVE $3.33
- CLYM N/A
- Resistance Level
- INVE $3.61
- CLYM N/A
- Average True Range (ATR)
- INVE 0.12
- CLYM 0.00
- MACD
- INVE 0.03
- CLYM 0.00
- Stochastic Oscillator
- INVE 92.45
- CLYM 0.00
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.